Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Targeting casein kinase 1α-mediated FADD phosphorylation restores sensitivity in select CDK4/6 inhibitor-resistant breast cancer models.
Journal: The Journal of clinical investigation
Published: July 28, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Right-Sizing Locoregional Management in the Era of Neoadjuvant Therapy for Breast Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2026
Adverse Events in a Randomized Trial Comparing Radiotherapy with or without Olaparib for Inflammatory Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: April 13, 2026
Prognostic Value of MammaPrint in Diverse Populations: Evaluating Racial Disparities in Breast Cancer Outcomes.
Journal: JCO precision oncology
Published: April 09, 2026
Prognostic consistency of oncotype DX® molecular assay across racial groups in early-stage hormone receptor-positive breast cancer.
Journal: NPJ breast cancer
Published: September 30, 2025
Overlooked Risk in Cancer Care: Failure of Medical Reconciliation.
Journal: JCO oncology practice
Published: June 24, 2025
Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibition.
Journal: NPJ breast cancer
Published: June 09, 2025
Response to Li, Liu, Duan, et al.
Journal: Journal of the National Cancer Institute
Published: April 22, 2025
Impact of Patient Navigation on Radiation Therapy Completion in Black Breast Cancer Patients: Early Phase I Trial Results From the Navigator-Assisted Hypofractionation (NAVAH) Program.
Journal: American journal of clinical oncology
Published: April 22, 2025
Impact of Chemotherapy on Financial Toxicity in African American Breast Cancer Patients: Early Findings From the Navigator-Assisted Hypofractionation Phase I Clinical Trial.
Journal: American journal of clinical oncology
Published: April 10, 2025
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling.
Journal: Neoplasia (New York, N.Y.)
Published: March 31, 2025
Last Updated: 09/26/2026